Intravitreal Ranibizumab versus Isovolemic Hemodilution in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized, Multicenter Trial

Publisher： Karger

E-ISSN： 1423-0267|233|1|8-17

ISSN： 0030-3755

Source： Ophthalmologica, Vol.233, Iss.1, 2014-12, pp. : 8-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 227, Iss. 3, 2011-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion

By  

Annals of Ophthalmology, Vol. 39, Iss. 4, 2007-12 ,pp. : 307-312

Humana Press, Inc

Access to resources Recommend Favorite

1-year results of intravitreal aflibercept treatment for macular edema due to central retinal vein occlusion

By Stewart Michael W  

Expert Review of Ophthalmology, Vol. 8, Iss. 3, 2013-06 ,pp. : 241-244

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite